JUN and Hepatic fibrosis: Of the 49 pathways, several are potentially directly involved in liver fibrosis, cirrhosis, alcohol-related liver disease, and liver regeneration, including pathways associated with the AP-1 network, estrogen/androgen signalling pathways, and the CXCR4 receptor.